Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund phase 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submitting (PDF) for an ...

Frazier Lifestyle Sciences gets $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has sourced an additionally $630 thousand for its fund focused on littl...

GigaGen amasses approximately $135M BARDA bucks to hammer botulism

.Antitoxin fan GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its technology to tac...

GPCR firm Septerna files for IPO on strength of preclinical information

.Septerna will figure out how a biotech without "any type of purposeful clinical information" fares ...

Kurma closes to begin with $154M loot for biggest biotech fund yet

.International VC company Kurma Allies has revealed its own newest biotech fund, along with 140 thou...

Prothena markets one officer while another leaves-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings and ...

Editas capitalize Tip Cas9 licensing rights for $57M

.Against the backdrop of a Cas9 patent fight that rejects to die, Editas Medicine is moneying in a p...

Ultragenyx fine-tunes gene therapy dosing to call up efficacy

.A minority of individuals taking Ultragenyx Drug's Wilson health condition genetics treatment UX701...

Biopharma layoff price maintains in Q3: Ferocious Biotech review

.As summer months warmth looks to cool down winds, really hopes that this year would certainly take ...

J &amp J loses stage 2 dengue candidate in most recent change coming from injections

.Johnson &amp Johnson's deprioritization of its own contagious disease pipeline has actually claimed...